Division of Pulmonology, Department of Internal Medicine, The Armed Forces Goyang Hospital, Goyang-si, South Korea.
Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea.
PLoS One. 2021 Mar 1;16(3):e0247868. doi: 10.1371/journal.pone.0247868. eCollection 2021.
The present study evaluated the association of electronic cigarette (EC) exposure with serum uric acid (UA) level and hyperuricemia (HUA) using a nationally representative sample of South Korea.
This study included 10,692 participants (9,905, 609, and 178, never, ever, and current EC users, respectively). Urinary cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels were used to determine conventional smoking exposure among EC users. The association between EC use and UA level was evaluated by linear regression analysis. Multivariable logistic regression analysis was used to assess the association between EC and HUA. Subgroup analysis confined to cotinine-verified active smokers was performed to address the association between the dual use of EC and combustible cigarettes and serum UA levels.
The serum UA level was highest among current EC users, followed by ever and never EC users. The prevalence of HUA was 26.2%, 19.3%, and 10.8% in current, ever, and never EC users, respectively. Although EC exposure was positively associated with HUA in a dose-dependent manner only in men (Ptrend = 0.04), a similar tendency was also observed in women with marginal significance (Ptrend = 0.102). The positive association of HUA with EC exposure was more apparent among dual users (odds ratio [OR] = 1.96, 95% confidence interval [CI]: 1.29-2.99) than among those who only smoked combustible cigarettes.
EC exposure was associated with higher serum UA level and higher OR of HUA. The positive association between EC exposure and HUA was more prominent in dual users who concurrently consumed EC and combustible cigarettes.
本研究使用韩国全国代表性样本评估了电子烟(EC)暴露与血清尿酸(UA)水平和高尿酸血症(HUA)之间的关联。
本研究纳入了 10692 名参与者(从未使用、曾经使用和当前使用 EC 的分别为 9905、609 和 178 人)。使用尿可替宁和 4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁醇(NNAL)水平来确定 EC 使用者的常规吸烟暴露情况。采用线性回归分析评估 EC 使用与 UA 水平之间的关系。采用多变量 logistic 回归分析评估 EC 与 HUA 之间的关系。对经可替宁确认为活跃吸烟者的亚组进行分析,以解决 EC 和可燃香烟双重使用与血清 UA 水平之间的关系。
当前 EC 用户的血清 UA 水平最高,其次是曾经使用和从未使用 EC 的用户。当前、曾经和从未使用 EC 的 HUA 患病率分别为 26.2%、19.3%和 10.8%。尽管 EC 暴露仅在男性中呈剂量依赖性与 HUA 呈正相关(Ptrend = 0.04),但在女性中也观察到类似的趋势,具有边缘显著性(Ptrend = 0.102)。在双重使用者中,HUA 与 EC 暴露之间的正相关更为明显(比值比[OR] = 1.96,95%置信区间[CI]:1.29-2.99),高于仅吸烟可燃香烟的人群。
EC 暴露与血清 UA 水平升高和 HUA 的 OR 升高有关。EC 暴露与 HUA 之间的正相关在同时使用 EC 和可燃香烟的双重使用者中更为明显。